Your browser doesn't support javascript.
loading
Association between CSF biomarkers, hippocampal volume and cognitive function in patients with amnestic mild cognitive impairment (MCI).
Nathan, Pradeep J; Lim, Yen Ying; Abbott, Rosemary; Galluzzi, Samantha; Marizzoni, Moira; Babiloni, Claudio; Albani, Diego; Bartres-Faz, David; Didic, Mira; Farotti, Lucia; Parnetti, Lucilla; Salvadori, Nicola; Müller, Bernhard W; Forloni, Gianluigi; Girtler, Nicola; Hensch, Tilman; Jovicich, Jorge; Leeuwis, Annebet; Marra, Camillo; Molinuevo, José Luis; Nobili, Flavio; Pariente, Jeremie; Payoux, Pierre; Ranjeva, Jean-Philippe; Rolandi, Elena; Rossini, Paolo Maria; Schönknecht, Peter; Soricelli, Andrea; Tsolaki, Magda; Visser, Pieter Jelle; Wiltfang, Jens; Richardson, Jill C; Bordet, Régis; Blin, Olivier; Frisoni, Giovanni B.
Affiliation
  • Nathan PJ; Heptares Therapeutics Ltd, Cambridge, UK; Brain Mapping Unit, Department of Psychiatry, University of Cambridge, Cambridge, UK. Electronic address: pradeep.nathan@heptares.com.
  • Lim YY; The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Melbourne, Victoria, Australia. Electronic address: yen.lim@florey.edu.au.
  • Abbott R; Cambridge Cognition, Cambridge, UK.
  • Galluzzi S; Lab Alzheimer's Neuroimaging & Epidemiology, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy.
  • Marizzoni M; Lab Alzheimer's Neuroimaging & Epidemiology, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy.
  • Babiloni C; Department of Physiology and Pharmacology, University of Rome "La Sapienza", Rome, Italy; IRCCS San Raffaele Pisana of Rome, Italy.
  • Albani D; Department of Neuroscience, Mario Negri Institute for Pharmacological Research, Milano, Italy.
  • Bartres-Faz D; Department of Psychiatry and Clinical Psychobiology, Faculty of Medicine, University of Barcelona and Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalunya, Spain.
  • Didic M; Aix-Marseille Université, INSERM, INS UMR_S 1106, Marseille, France; Service de Neurologie et Neuropsychologie, APHM Hôpital Timone Adultes, Marseille, France.
  • Farotti L; Clinica Neurologica, Centro Disturbi della Memoria, Università di Perugia, Ospedale Santa Maria della Misericordia, Perugia, Italy.
  • Parnetti L; Clinica Neurologica, Centro Disturbi della Memoria, Università di Perugia, Ospedale Santa Maria della Misericordia, Perugia, Italy.
  • Salvadori N; Clinica Neurologica, Centro Disturbi della Memoria, Università di Perugia, Ospedale Santa Maria della Misericordia, Perugia, Italy.
  • Müller BW; Department of Psychiatry and Psychotherapy, LVR-Hospital Essen, Faculty of Medicine, University of Duisburg-Essen, Essen, Germany.
  • Forloni G; Department of Neuroscience, Mario Negri Institute for Pharmacological Research, Milano, Italy.
  • Girtler N; Department of Neuroscience (DINOGMI), Clinical Neurology, University of Genoa, Genoa, Italy.
  • Hensch T; Department of Psychiatry and Psychotherapy, University of Leipzig, Leipzig, Germany.
  • Jovicich J; Center for Mind/Brain Sciences, University of Trento, Rovereto, Trento, Italy.
  • Leeuwis A; Department of Neurology, Alzheimer Centre, VU Medical Centre, Amsterdam, the Netherlands.
  • Marra C; Department of Gerontology, Neurosciences and Orthopedics, Institute of Neurology, Catholic University, Policlinic A. Gemelli Foundation, Rome, Italy.
  • Molinuevo JL; Alzheimer's Disease Unit and Other Cognitive Disorders Unit, Hospital Clínic de Barcelona, and Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalunya, Spain.
  • Nobili F; Department of Neuroscience (DINOGMI), Clinical Neurology, University of Genoa, Genoa, Italy.
  • Pariente J; INSERM, Imagerie cérébrale et handicaps neurologiques UMR 825, Toulouse, France.
  • Payoux P; INSERM, Imagerie cérébrale et handicaps neurologiques UMR 825, Toulouse, France.
  • Ranjeva JP; Aix-Marseille Université, INSERM, INS UMR_S 1106, Marseille, France; Service de Neurologie et Neuropsychologie, APHM Hôpital Timone Adultes, Marseille, France.
  • Rolandi E; Lab Alzheimer's Neuroimaging & Epidemiology, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy.
  • Rossini PM; Department of Gerontology, Neurosciences and Orthopedics, Institute of Neurology, Catholic University, Policlinic A. Gemelli Foundation, Rome, Italy.
  • Schönknecht P; Department of Psychiatry and Psychotherapy, University of Leipzig, Leipzig, Germany.
  • Soricelli A; SDN Istituto di Ricerca Diagnostica e Nucleare, Napoli, Italy.
  • Tsolaki M; 3rd Neurologic Clinic, Medical School, G. Papanikolaou Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Visser PJ; Department of Neurology, Alzheimer Centre, VU Medical Centre, Amsterdam, the Netherlands.
  • Wiltfang J; Department of Psychiatry and Psychotherapy, LVR-Hospital Essen, Faculty of Medicine, University of Duisburg-Essen, Essen, Germany; Department of Psychiatry and Psychotherapy, University Medical Center (UMG), Georg-August-University, Goettingen, Germany.
  • Richardson JC; Neurosciences Therapeutic Area, GlaxoSmithKline R&D, Stevenage, UK.
  • Bordet R; University of Lille, Inserm, CHU Lille, U1171 - Degenerative and Vascular Cognitive Disorders, Lille, France.
  • Blin O; Mediterranean Institute of Cognitive Neurosciences (INCM), UMR-CNRS (6193), Aix Marseille University, Marseille, France.
  • Frisoni GB; Lab Alzheimer's Neuroimaging & Epidemiology, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy; Memory Clinic and LANVIE - Laboratory of Neuroimaging of Aging, University Hospitals and University of Geneva, Geneva, Switzerland.
Neurobiol Aging ; 53: 1-10, 2017 05.
Article in En | MEDLINE | ID: mdl-28189924
Few studies have examined the relationship between CSF and structural biomarkers, and cognitive function in MCI. We examined the relationship between cognitive function, hippocampal volume and cerebrospinal fluid (CSF) Aß42 and tau in 145 patients with MCI. Patients were assessed on cognitive tasks from the Cambridge Neuropsychological Test Automated Battery (CANTAB), the Geriatric Depression Scale and the Functional Activities Questionnaire. Hippocampal volume was measured using magnetic resonance imaging (MRI), and CSF markers of Aß42, tau and p-tau181 were also measured. Worse performance on a wide range of memory and sustained attention tasks were associated with reduced hippocampal volume, higher CSF tau and p-tau181 and increased tau/Aß42 ratio. Memory tasks were also associated with lower ability to conduct functional activities of daily living, providing a link between AD biomarkers, memory performance and functional outcome. These results suggest that biomarkers of Aß and tau are strongly related to cognitive performance as assessed by the CANTAB, and have implications for the early detection and characterization of incipient AD.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptide Fragments / Amyloid beta-Peptides / Tau Proteins / Cognition / Cognitive Dysfunction / Hippocampus Type of study: Diagnostic_studies / Risk_factors_studies / Screening_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Neurobiol Aging Year: 2017 Document type: Article Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptide Fragments / Amyloid beta-Peptides / Tau Proteins / Cognition / Cognitive Dysfunction / Hippocampus Type of study: Diagnostic_studies / Risk_factors_studies / Screening_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Neurobiol Aging Year: 2017 Document type: Article Country of publication: United States